companydata.dkSpeciallægeselskabet MORF ApS: Financial statements 2023
CVR: 25194446
Speciallægeselskabet MORF ApS (CVR 25194446) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,378,755 and a net result of DKK 1,024,397 compared with DKK -42,717 the year before. That is an increase of 35.6% compared with the year before. Equity amounted to DKK 2,208,106. The solvency ratio was 77.1%. The company had 1 employee in the financial year.
- Gross Profit
- 3,378,755 kr.
- Profit/Loss
- 1,024,397 kr.
- Equity
- 2,208,106 kr.
- Total Assets
- 2,862,135 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 3.4 mio. | 1 mio. | 2.2 mio. | 1 |
| 2022 | - | 2.5 mio. | -43 t. | 1.3 mio. | 2 |
| 2021 | - | 2.4 mio. | 525 t. | 1.5 mio. | 2 |
| 2020 | - | 2.2 mio. | 329 t. | 1 mio. | 2 |
| 2019 | - | 2.4 mio. | 341 t. | 818 t. | 2 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of September 13, 2023, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of Speciallægeselskabet MORF ApS.
About Speciallægeselskabet MORF ApS
Speciallægeselskabet MORF ApS is a Danish company of the type Anpartsselskab based in Havdrup, founded in 2000. The company is registered under the industry Speciallægers aktiviteter. The management consists of Søren Lecker. The company is owned by Søren Lecker. The company has 7 employees. In 2025, the company reported a gross profit of DKK -12,294 and a net result of DKK 123,020 compared with DKK -2,916 the year before. Equity amounted to DKK 1,428,210.